Sep 25, 2024 7:30 am EDT Acasti Announces Completion of Patient Enrollment in Pivotal Phase 3 STRIVE-ON Safety Trial of GTX-104
Sep 5, 2024 10:35 am EDT Acasti to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
Aug 9, 2024 8:00 am EDT Acasti Announces First Fiscal Quarter 2025 Financial Results, Provides Business Update
Jun 27, 2024 4:05 pm EDT Acasti Announces Achievement of 50% Enrollment in Pivotal Phase 3 STRIVE-ON Safety Trial
Feb 12, 2024 8:00 am EST Acasti Announces Third Fiscal Quarter 2024 Financial Results and Business Highlights
Dec 13, 2023 8:00 am EST Acasti to Participate in Upcoming San Francisco Investor Conferences in January 2024